Gayanan, Joemer .

HRN: 14-68-64  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/26/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/26/2025
04/01/2025
IV
1.5g
Q8h
Cellulitis
Waiting Final Action 
03/26/2025
CEFTAZIDIME 1GM (VIAL)
03/26/2025
04/01/2025
IV
1g
Q8h
CAPMR
Waiting Final Action 
03/27/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
03/27/2025
04/10/2025
PO
4ml
Qid
Oral Candidiasis
Waiting Final Action 
03/30/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/30/2025
04/06/2025
IV
4.5gms
Q6
T/C Sepsis
Waiting Final Action 
03/30/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
03/30/2025
04/06/2025
IV
500mg
OD
T/C Sepsis
Waiting Final Action 
04/01/2025
MUPIROCIN 2%, 15G (TUBE)
04/01/2025
04/08/2025
TOPICAL
Tube
2x A Day
Cellulitis On Lips
Waiting Final Action 
04/29/2025
CEFTRIAXONE 1G (VIAL)
04/29/2025
05/06/2025
IV
2gm
OD
CAP MR
Waiting Final Action 
04/29/2025
AZITHROMYCIN 500MG TABLET (TAB)
04/29/2025
05/04/2025
PO
500mg
OD
CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: